META Pharmaceuticals Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
META Pharmaceuticals Inc. - overview
Established
2021
Location
Shenzhen, Guangdong, China
Primary Industry
Pharmaceuticals
About
Founded in 2021, and based in Shenzhen, China, META Pharmaceuticals Inc. is a biotech company that focuses on the development of small molecule innovative drugs based on immunometabolism targets. Ke Xu, the company's co-founder and CEO, worked as a consultant at PreScouter Inc. and provided consulting services to well-known biotech companies Taconic and Tesaro.
The company's founding team came from two U. S. research hospitals, Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. In February 2025, the firm raised series A funding led by returning investor XtalPi Inc..
Other returning investor IMO Ventures and new investor Yael Capital also participated in the round. The company's main products include Meta-01 inhibitors, Meta-02 inhibitors and Meta-03 inhibitors, etc. Meta-01 inhibitors are used in multiple sclerosis, systemic lupus erythematosus, allergic asthma, rheumatoid arthritis, ulcerative colitis and other diseases. Meta-02 inhibitors and Meta-03 inhibitors are used in autoimmune diseases.
The company’s revenue is generated by providing drugs for autoimmune and metabolic diseases. The company will use the series A funding to accelerate the advancement of two pipeline drugs into clinical trials and further expand the development of its AI metabolic enzyme target discovery platform.
Current Investors
Tiantu Capital, XtalPi Inc., IMO Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Specialty Pharmaceuticals
Website
www.metabiopharma.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.